Theca Interna Cells are a specialized cell type located in the ovarian follicles, structures crucial for female reproductive function. Found in the ovarian cortex surrounding the developing oocyte, theca interna cells are part of the theca layer, which also includes the outer theca externa cells. These cells are involved in the regulation of ovarian steroidogenesis, particularly androgen production. In response to luteinizing hormone (LH) stimulation, theca interna cells undergo steroidogenesis, producing androgens such as testosterone. These androgens serve as precursors for the synthesis of estrogens by the adjacent granulosa cells, contributing to the overall hormonal milieu of the ovarian follicle. Theca interna cells express various enzymes involved in steroidogenesis, including cytochrome P450 enzymes. Proper functioning of theca interna cells is essential for the follicular development and the menstrual cycle. Dysregulation of theca cell activity can lead to hormonal imbalances, impacting fertility and contributing to conditions such as polycystic ovary syndrome (PCOS). Research on theca interna cells provides insights into ovarian physiology and the intricate hormonal regulation essential for reproductive health. Understanding the molecular mechanisms governing theca cell function is crucial for fertility treatments and addressing reproductive disorders in women. Ongoing studies continue to elucidate the complexities of theca interna cells and their role in ovarian function.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy